NCT06133101View on ClinicalTrials.gov

Impact of Soymilk on Liver Disease Severity of Children With Non-alcoholic Fatty Liver Disease (NAFLD)

PHASE2RecruitingINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

January 15, 2024

Primary Completion Date

March 31, 2026

Study Completion Date

June 30, 2026

Conditions
Non-Alcoholic Fatty Liver Disease
Interventions
DRUG

Standard Soy Milk

Consumption of commercially available soy milk

DRUG

2% Fat Cow's Milk

Consumption of commercially available 2% cow's milk

Trial Locations (1)

45229

RECRUITING

Cincinnati Children's Hospital Medical Center, Cincinnati

All Listed Sponsors
lead

Marialena Mouzaki

OTHER